EnBio Holdings Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Yoshikazu Nakamura

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.5yrs
CEO ownership5.3%
Management average tenureno data
Board average tenure5yrs

Recent management updates

Recent updates

EnBio Holdings (TSE:6092) Is Paying Out A Dividend Of ¥8.00

Dec 14
EnBio Holdings (TSE:6092) Is Paying Out A Dividend Of ¥8.00

EnBio Holdings (TSE:6092) Has Affirmed Its Dividend Of ¥8.00

Nov 16
EnBio Holdings (TSE:6092) Has Affirmed Its Dividend Of ¥8.00

Returns On Capital At EnBio Holdings (TSE:6092) Have Stalled

Aug 07
Returns On Capital At EnBio Holdings (TSE:6092) Have Stalled

CEO

Yoshikazu Nakamura (51 yo)

1.5yrs

Tenure

Mr. Yoshikazu Nakamura is Independent Outside Director of User Local, Inc. since September 2024 and was External Auditor. He is President at EnBio Holdings, Inc. since June 2023. He serves as an Independen...


Board Members

NamePositionTenureCompensationOwnership
Yoshikazu Nakamura
President & Representative Director20.5yrsno data5.35%
¥ 253.2m
Takahiro Hoshino
Independent Outside Director1.5yrsno data0.12%
¥ 5.9m
Minoru Nishimura
Chairman of the Board16.9yrsno data6.13%
¥ 290.4m
Tadahide Kameyama
Independent Outside Director8.5yrsno data0.0012%
¥ 58.7k
Koichiro Hirata
Independent Outside Director1.5yrsno data2.47%
¥ 117.2m
Ichiro Namekawa
Independent Outside Director1.5yrsno data0.19%
¥ 8.8m
Toshihito Yamamoto
Director5.5yrsno data0.19%
¥ 9.1m
Yukinobu Yokomizo
Director5.5yrsno data0.17%
¥ 8.3m
Yuki Odake
Independent Outside Director4.5yrsno data0.012%
¥ 585.8k
Kazuo Takayama
Independent Outside Director1.5yrsno datano data

5.0yrs

Average Tenure

61.5yo

Average Age

Experienced Board: 6092's board of directors are considered experienced (5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 16:45
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EnBio Holdings, Inc is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yoko MizoguchiIchiyoshi Research Institute Inc.
Eiji TomaruMizuho Securities Co., Ltd.